Pvp-22Ic04
Research payments
$523,528
Through program year 2025, $523,528 in research payments was reported against Pvp-22Ic04, across 58 payments, paid by Provepharm Inc..
- Paid by
- Provepharm Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $456,145 | 32 |
| 2024 | Research | $38,498 | 19 |
| 2023 | Research | $28,885 | 7 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Kalpesh Patel Tucson, AZ Named on 11 payments
- Robert Sherman Pembroke Pines, FL Named on 9 payments
- Steven Robison Idaho Falls, ID Named on 6 payments
- Lucas Wiegand Orlando, FL Named on 5 payments
- Daniel Yelfimov San Antonio, TX Named on 4 payments
- Miles Murphy Allentown, PA Named on 4 payments
- Bilal Chughtai New York, NY Named on 4 payments
- Mark White Albany, NY Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.